Clinical Trial News and Research

RSS

Single-cell transcriptomic analysis reveals specific cellular signatures for kidney transplant rejection

Imagine a day when a urine test could inform a doctor precisely why a kidney transplant patient was experiencing organ rejection and suggest the best medication for specifically addressing the problem.

28 Jun 2023

SARS-CoV-2 mRNA vaccination induces an immune response in the nasal mucosa, study finds

Respiratory viruses are known for their ability to enter the body through the eyes, nose, or mouth. Our bodies know that, too.

28 Jun 2023

Personalized dosing improves outcomes for men with metastatic castration-resistant prostate cancer

By monitoring early-response biomarkers in men undergoing 177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes.

26 Jun 2023

New computational technique shows promise for identifying different subtypes of Alzheimer's disease

A new computational technique that combines genomic and tau PET imaging data promises a more personalized approach for subtyping Alzheimer's disease.

26 Jun 2023

Researchers pinpoint a key feature that leads to aggressive spread of colon cancer

In a significant development in the fight against fatal cancers, University of Otago researchers have pinpointed a key feature that leads to the aggressive spread of colon cancer.

26 Jun 2023

UCalgary researchers discover how Leishmania parasites hide within the body

University of Calgary researchers have discovered how Leishmania parasites hide within the body to cause Leishmaniasis. The tiny parasites are carried by infected sand flies.

26 Jun 2023

Researchers identify a potential new drug for NASH-related fibrosis

Researchers at the University of California San Diego School of Medicine have led a study to examine a potential new treatment option for patients with nonalcoholic steatohepatitis (NASH)-related fibrosis.

26 Jun 2023

New hope for cystic fibrosis patients as groundbreaking treatment enters clinical trial

Clinical testing is underway for a potentially groundbreaking new treatment for cystic fibrosis. Pioneered by scientists at Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign and the Carver College of Medicine at the University of Iowa in partnership with the spin-out biotechnology company, cystetic Medicines, this promising inhalable molecular prosthetic is intended to improve lung function in people with CF who cannot benefit from current therapies.

26 Jun 2023

Type 2 diabetes is frequently overlooked in clinical trials, analysis reveals

New analysis of official records from the National Institute of Health (NIH) have revealed that just 365,000 people took part in a clinical trial for Type 2 Diabetes in 2021, despite 37.3 million people in the US living with the condition - or more than 11% of the population.

24 Jun 2023

New category of depression identified

Scientists at Stanford Medicine conducted a study describing a new category of depression - labeled the cognitive biotype - which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed antidepressants.

23 Jun 2023

New study offers hope for women suffering from axillary web syndrome

Axillary web syndrome, also known as lymphatic thrombus, is a complication in the clinical manifestations suffered by many women after overcoming breast cancer, mainly affecting their shoulder mobility.

23 Jun 2023

Cell and gene therapy CDMO Andelyn Biosciences celebrates over 20 years of leadership and innovation with opening of new 180,000 square foot manufacturing headquarters

Andelyn Biosciences, a pioneer in the development and manufacturing of cell and gene therapies, today formally inaugurates its new manufacturing headquarters, the Andelyn Corporate Center (ACC), located in the Innovation District in Columbus, Ohio.

From Andelyn Biosciences 23 Jun 2023

Study finds the risk of recurrence of active disease in older patients with MS after discontinuing therapy

An article published today in the journal Lancet Neurology evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.

23 Jun 2023

PMC to improve potential alternative pain management treatments for NFL players

The National Football League and the NFL Players Association (NFLPA) announced today they are awarding a grant to Emory University researchers to study innovative, first-of-their-kind, alternative pain management methods that could benefit NFL players and society at large.

23 Jun 2023

Clinical Trial News and Research

Single-cell transcriptomic analysis reveals specific cellular signatures for kidney transplant rejection

SARS-CoV-2 mRNA vaccination induces an immune response in the nasal mucosa, study finds

Personalized dosing improves outcomes for men with metastatic castration-resistant prostate cancer

New computational technique shows promise for identifying different subtypes of Alzheimer's disease

Researchers pinpoint a key feature that leads to aggressive spread of colon cancer

UCalgary researchers discover how Leishmania parasites hide within the body

Researchers identify a potential new drug for NASH-related fibrosis

New hope for cystic fibrosis patients as groundbreaking treatment enters clinical trial

Type 2 diabetes is frequently overlooked in clinical trials, analysis reveals

New category of depression identified

New study offers hope for women suffering from axillary web syndrome

Cell and gene therapy CDMO Andelyn Biosciences celebrates over 20 years of leadership and innovation with opening of new 180,000 square foot manufacturing headquarters

Study finds the risk of recurrence of active disease in older patients with MS after discontinuing therapy

PMC to improve potential alternative pain management treatments for NFL players

Plant-based foods may be a key to preventing childhood obesity

MD Anderson and Ochsner Health join forces to advance cancer care in Louisiana

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

Do Panax notoginseng saponins (Xuesaitong soft capsules) improve function in patients with ischemic stroke?

Hypertension drug shown to prevent post-traumatic headaches

Single mutation of the hepatitis E virus stands in the way of sofosbuvir drug's effectiveness

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Life Science Microscopy (2nd Edition)

Event guide: 2nd World RNA-Based Therapeutics & Vaccines Summit Korea

New horizons in drug discovery: High-throughput & target-to-therapy advances

A practical guide to lipid nanoparticle formulation and resizing

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance